Guest: Adam M. Brufsky, MD, PhD The introduction of cyclin-dependent kinase (CDK) 4/6 inhibitors has drastically changed the treatment landscape of hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastati

Guest: Hope S. Rugo, MD, FASCO The introduction of cyclin-dependent kinase (CDK) 4/6 inhibitors has drastically changed the treatment landscape of hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic

Guest: Hope S. Rugo, MD, FASCO Guest: Adam M. Brufsky, MD, PhD The introduction of cyclin-dependent kinase (CDK) 4/6 inhibitors has drastically changed the treatment landscape of hormone receptor-positive/human epidermal growth factor recept

Host: Caron A. Jacobson, MD Guest: Matthew Lunning, DO Guest: Loretta J. Nastoupil, MD Since the first chimeric antigen receptor (CAR) T-cell therapy was approved by the US Food and Drug Administration (FDA) for the treatment of large B-

Host: Caron A. Jacobson, MD Since the first chimeric antigen receptor (CAR) T-cell therapy was approved by the US Food and Drug Administration (FDA) for the treatment of large B-cell lymphoma (LBCL) in the third or later line of therapy, there h

Host: Jrgen Floege, MD Guest: Jonathan Barratt, PhD Guest: David Jayne, MD Patients with chronic kidney disease often have a multitude of comorbidities which may present challenges in diagnosis, treatment, and management. In addition, the limita

Host: Danielle Becker, MD, MS, FAES Host: Ahmed Abdelmoity, MD Guest: Deborah Holder, MD Guest: John Stern, MD Vagus nerve stimulation (VNS) therapy is an add-on neuromodulation treatment designed for adults and children diagnosed wi

Host: Frederic Rahbari-Oskoui, MD, MSc This Expert Exchange webcast is designed to help improve clinicians ability to apply pharmacologic and non-pharmacologic strategies in the management of patients with ADPKD.

Host: Adam DeVore, MD Guest: Lauren Barron, MD Guest: Navin Kapur, MD Less than 20% of patients admitted to the hospital with new-onset heart failure are assessed for coronary artery disease (CAD) even though revascularization can improv

Host: Mark A. Atkinson, PhD Guest: Linda DiMeglio, MD, MPH Autoantibody Screening to Identify Risk for Type 1 DiabetesT1D defines a continuum that begins during an asymptomatic prodrome before the disease manifests clinically. One of the cha